Search - tctmd.com

Displaying 121 - 140 of 191

Sort: Relevancy | Date

Presentation TCT 2021

Case Outcome

Presenter: Yousif Ahmad

November 04, 2021

Presentation TCT 2021

What the Guidelines Say

Presenter: Davide Capodanno

November 04, 2021

Presentation TCT 2021

Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG?

Presenter: Yousif Ahmad

November 04, 2021

Presentation TCT 2021

What the Guidelines Say

Presenter: Vera Rigolin

November 04, 2021

Presentation TCT 2021

Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI?

Presenter: Karim Al-Azizi

November 04, 2021

Presentation TCT 2021

Beyond Guidelines – Novel Approaches to Achieve Evidence-Based Practice

Presenter: Catherine Otto

November 04, 2021

Presentation TCT 2021

Guidelines – What They Are And What They Are Not

Presenter: Robert Bonow

November 04, 2021

Presentation TCT 2021

Debate 1: Pro – Functional Testing Matters; We Need to Follow the ACC/AHA Guidelines

Presenter: Raymond Kwong

November 04, 2021

Presentation AHA 2019

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

Presenter: Matthew Budoff

November 18, 2019

Presentation AHA 2018

REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Presenter: Deepak L Bhatt

November 16, 2018

Presentation AHA 2018

Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting

Presenter: Heribert Schunkert

November 14, 2018

Presentation AHA 2018

REGROUP Trial: A Prospective, Randomized TRial Comparing Endoscopic vs. Open Vein Grafts in CABG Surgery

Presenter: Marco A. Zenati

November 13, 2018

Presentation AHA 2018

PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure

Presenter: Eric J Velazquez

November 12, 2018

Alert-Based Computerized Decision Support to Increase Anticoagulation Prescription Prevents Stroke and Myocardial Infarction in High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Presentation AHA 2018

High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Presenter: Gregory Piazza

November 11, 2018

Presentation AHA 2018

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

Presenter: Sotirios Tsimikas

November 11, 2018

Presentation AHA 2018

DECLARE - TIMI 58

Presenter: Stephen Wiviott

November 11, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Stephan Windecker

June 21, 2018

Presentation

Taking the Reins on Systems of Care for STEMI Patients - AHA Mission: Lifeline Program

May 01, 2018

Presentation AHA 2017

Insights from the FOURIER Trial

Presenter: Marc P. Bonaca

November 15, 2017

Presentation AHA 2017

Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

Presenter: Andre Lamy

November 15, 2017

Advertisement

Case Outcome

What the Guidelines Say

Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG?

What the Guidelines Say

Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI?

Beyond Guidelines – Novel Approaches to Achieve Evidence-Based Practice

Guidelines – What They Are And What They Are Not

Debate 1: Pro – Functional Testing Matters; We Need to Follow the ACC/AHA Guidelines

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting

REGROUP Trial: A Prospective, Randomized TRial Comparing Endoscopic vs. Open Vein Grafts in CABG Surgery

PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure

High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

DECLARE - TIMI 58

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Taking the Reins on Systems of Care for STEMI Patients - AHA Mission: Lifeline Program

Insights from the FOURIER Trial

Cost Impact of Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content